首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1674187

按服務類型、分子類型和地區分類的醫藥契約製造市場

Contract Pharmaceutical Manufacturing Market, By Service Type, By Molecule Type, By Geography

出版日期: 2025年02月14日 | 出版商:

Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球醫藥契約製造市場規模預計為 2,322.8 億美元，預計到 2032 年將達到 4,500.7 億美元，2025 年至 2032 年的複合年成長率為 9.9%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	2322.8億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	9.90％	2032 年金額預測	4507億美元

數字。醫藥契約製造市場區域佔有率（%）（2025 年）

過去幾年，全球醫藥契約製造市場一直穩定成長。製藥契約製造是指將某些製藥流程（例如藥品製造、包裝和測試）外包給稱為契約製造組織 (CMO) 的第三方公司。降低製造成本和關注核心競爭力的需求日益增加，這是製藥公司將其製造需求外包給 CMO 的主要驅動力。此外，由於專利到期導致的持續損失、學名藥需求的增加以及藥物開發和商業化活動外包的增加，預計將在未來幾年進一步推動全球製藥契約製造市場的成長。

市場動態

全球醫藥契約製造市場的成長受到全球心血管疾病盛行率上升和老齡人口成長（心律不整的風險更高）的推動。根據世界衛生組織（WHO）的資料，心血管疾病是全球第一大死因，每年有超過1700萬人死於心臟病和中風。此外，專注於小型化和延長電池壽命的技術創新正在擴大心律調節器植入的適應症。然而，心律調節器手術的高成本以及導線缺陷和感染等設備併發症的風險可能會阻礙市場的成長。

研究的主要特點

本報告對全球醫藥契約製造市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
全球醫藥契約製造市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
主要企業包括龍沙集團 (Lonza Group)、勃林格殷格翰公司 (Boehringer Ingelheim GmbH)、Genpact Limited、埃森哲公司 (Accenture plc)、昆泰跨國公司 (Quintiles Transnational Corporation)、百特 (Baxter)、雷迪博士實驗室 (Dr. Reddy's Laborator Inc.工業有限公司 (Teva Pharmaceutical Industries Ltd.)、Piramal Enterprises Ltd.、Covance, Inc.、Catalent, Inc.、Abbvie, Inc. 和 Celltrion。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、規模擴大、市場擴張和行銷策略做出明智的決策。
全球醫藥契約製造市場迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過全球醫藥契約製造市場分析中使用的各種策略矩陣更輕鬆地做出決策。

公司簡介
- Lonza Group
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion

第9章分析師建議

興衰
一致的機會地圖

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2397

Global Contract Pharmaceutical Manufacturing Market is estimated to be valued at USD 232.28 Bn in 2025 and is expected to reach USD 450.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 232.28 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.90%	2032 Value Projection:	USD 450.07 Bn

Figure. Contract Pharmaceutical Manufacturing Market Share (%), By Region 2025

Contract Pharmaceutical Manufacturing Market - IMG1

The global contract pharmaceutical manufacturing market has been witnessing steady growth over the past few years. Contract pharmaceutical manufacturing refers to the outsourcing of certain pharmaceutical processes such as manufacturing, packaging, and testing of pharmaceutical drugs to a third party company known as contract manufacturing organizations (CMOs). The growing need to reduce manufacturing costs and focus on core competencies are some of the key factors driving pharmaceutical companies to outsource their production requirements to CMOs. In addition, continued patent cliff losses, rising demand for generic drugs, and increasing outsourcing of drug development and commercialization activities are further expected to support the growth of the global contract pharmaceutical manufacturing market in the coming years.

Market Dynamics:

The global contract pharmaceutical manufacturing market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by World Health Organization, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global contract pharmaceutical manufacturing market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global contract pharmaceutical manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Lonza Group, Boehringer Ingelheim GmbH, Genpact Limited, Accenture plc, Quintiles Transnational Corporation, Baxter , Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd., Piramal Enterprises Ltd., Covance, Inc., Catalent, Inc., Abbvie, Inc., and Celltrion.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global contract pharmaceutical manufacturing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contract pharmaceutical manufacturing market.

Detailed Segmentation-

By Service Type:
- Contract Manufacturing Organization (CMO)
- API Manufacturing
- Final dosage form manufacturing
- Packaging
- Contract Research Organization (CRO)
- Drug Discovery
- Preclinical Studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical Coding and Writing
- Monitoring
- Clinical Data Management
- Others (Protocol Development, etc.)
By Molecule Type:
- Small Molecule
- Large Molecule
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Lonza Group
- Boehringer Ingelheim GmbH
- Genpact Limited
- Accenture plc
- Quintiles Transnational Corporation
- Baxter
- Reddy's Laboratories Ltd.
- Aurobindo Pharma
- Pfizer, Inc.
- The Almac Group
- Teva Pharmaceutical Industries Ltd.
- Piramal Enterprises Ltd.
- Covance, Inc.
- Catalent, Inc.
- Abbvie, Inc.
- Celltrion

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Molecule Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Contract Pharmaceutical Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Contract Manufacturing Organization (CMO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug Discovery
Preclinical Studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical Coding and Writing
Monitoring
Clinical Data Management
Others (Protocol Development, etc.)

6. Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Small Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Large Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Contract Pharmaceutical Manufacturing Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Genpact Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Accenture plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Quintiles Transnational Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dr. Reddy's Laboratories Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aurobindo Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- The Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Piramal Enterprises Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Covance, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbvie, Inc.
- Celltrion